Stock listing
Atea Pharmaceuticals, Inc.
Selected listing: AVIR · NASDAQ · USD · US
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR), Health Technology. Latest release Sep 8, 2026: Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual…
- Ticker
- NASDAQ:AVIR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. is a public company traded under the ticker AVIR in the American market. Atea focuses on developing innovative therapies for infectious diseases.
Latest news from Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
September 8, 2026
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026
August 5, 2026
Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus
July 27, 2026
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
Events
Research Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. company profile
View the public company page for Atea Pharmaceuticals, Inc. on 6ix.
Atea Pharmaceuticals, Inc. news
Read company news and market updates connected to Atea Pharmaceuticals, Inc..
Atea Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Atea Pharmaceuticals, Inc..